The hepatocyte growth factor (HGF)-c-Met receptor signalling axis is known to be dysregulated in NSCLC (Ichimura et al, 1996; Olivero et al, 1996; Tretiakova et al, 2011). The gene discussed is HGF; the disease is non-small cell lung carcinoma.